Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
NCT ID:
NCT01106508
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of advanced solid tumor, recurrent or refractory medulloblastoma or locally advanced or metastatic basal cell carcinoma)
* Protocol defined laboratory parameters
* Performance status ≤ 2
* Patients must have fully recovered from the prior effects of major surgery and from any acute toxicities of prior chemotherapy/radiotherapy
Exclusion Criteria:
* History of central nervous system tumors of symptomatic brain metastases (excludes medulloblastoma patients)
* Impairment of gastrointestinal function or unresolved nausea, vomiting or diarrhea
* Impairment of cardiac function or significant cardiac disease
* Pregnant or lactating women
* Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01106508
Study Brief:
Protocol Section:
NCT01106508